| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Uniqure N.V. (QURE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. QURE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 150.4K | $6.96M | - | |
| Other | 133.2K | $6.17M | -5,237 | |
| CFO | 63.9K | $2.96M | - | |
| Dir | 53.3K | $2.47M | -10,000 | |
| Dir | 40.1K | $1.86M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2021 | Soteropoulos Paula75 | Director | Sell | 504 | $37.60 | $18,950.40 | -7.3% | |
| Mar 2, 2021 | Astley-Sparke Philip47 | Director | Sell | 504 | $37.60 | $18,950.40 | -4.8% | |
| Mar 2, 2021 | Kaye Jack53 | Director | Sell | 504 | $37.60 | $18,950.40 | -2.7% | |
| Feb 15, 2021 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 3,800 | $35.38 | $134,451.50 | -0.8% | |
| Jan 29, 2021 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 7,000 | $35.58 | $249,048.80 | -1.5% | |
| Jan 28, 2021 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 31,499 | $36.63 | $1,153,786.03 | -2.5% | |
| Jan 28, 2021 | Kapusta Matthew C64 | CEO, CFO, Managing Director | Sell | 31,499 | $36.63 | $1,153,786.03 | -2.5% | |
| Jan 27, 2021 | Klemt Christian58 | Chief Accounting Officer | Sell | 8,399 | $37.56 | $315,496.86 | -7.4% | |
| Jan 27, 2021 | Kuta Alexander Edward III81 | Executive VP, Operations | Sell | 5,501 | $37.46 | $206,071.37 | -4.9% | |
| Jan 26, 2021 | Gut Robert69 | Chief Medical Officer | Sell | 604 | $39.09 | $23,610.36 | -1.5% |